Hyperglycemia as a predictor for no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction
Clinical innovations in health research-HJM · 2024
DOI: 10.24875/cihr.24000009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical innovations in health research-HJM, 2024. Verfasst von Oswaldo Aldana-Varela und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Aldana-Varela, O., Flores-Gómez, I. R., Villanueva-Balandrán, A., López-Castellanos, R. J., Victoria-Campos, J. L., & Santiago-González, M. D. L. (2024). Hyperglycemia as a predictor for no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction. Clinical innovations in health research-HJM. https://doi.org/10.24875/cihr.24000009
Vancouver
Aldana-Varela O, Flores-Gómez IR, Villanueva-Balandrán A, López-Castellanos RJ, Victoria-Campos JL, Santiago-González MDL. Hyperglycemia as a predictor for no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction. Clinical innovations in health research-HJM. 2024. doi:10.24875/cihr.24000009
BibTeX
@article{AldanaVarela2024,
author = {Aldana-Varela, Oswaldo and Flores-Gómez, Iván R. and Villanueva-Balandrán, Araceli and López-Castellanos, Ricardo J. and Victoria-Campos, José L. and Santiago-González, Ma. de Lourdes},
title = {Hyperglycemia as a predictor for no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction},
journal = {Clinical innovations in health research-HJM},
year = {2024},
doi = {10.24875/cihr.24000009}
}
EUVIMED